GLP-1 in India: How to Lose Fat, Not Muscle (2026)

GLP-1 in India: How to Lose Fat, Not Muscle (2026)

The scale is dropping faster than it ever has. That is the appeal of GLP-1 medicines, and in India, since generic semaglutide arrived in March 2026, more people than ever are hearing about them from doctors, colleagues and WhatsApp groups. What gets talked about less is what exactly the scale is measuring. When someone loses 12 kg on one of these medicines, some of that is fat. Some is lean mass. And a fraction of the lean mass is muscle.

This guide covers GLP-1 muscle loss in plain terms: what the large trials measured, why the numbers vary, what Indian readers should keep in mind, how to protect muscle, and how a body composition scan can help you and your doctor see what the weighing scale cannot. It is educational. These are prescription medicines, and every decision about starting, changing or stopping one belongs to you and your doctor.

Lean Mass Is Not the Same as Muscle

Before any numbers, one definition matters. Lean mass (or fat-free mass) is everything in your body that is not fat: muscle, but also organs, bone, connective tissue and water. When a scan says “lean mass fell by 3 kg”, it does not follow that 3 kg of muscle disappeared. A review published in Obesity Reviews in 2026 made the point directly: “lean”, “fat-free” and “skeletal muscle” mass are not synonyms, and the numbers depend on the measurement method.

Keep that in mind as you read the trial figures below. They describe lean mass, which is an upper bound on muscle loss, not a direct count.

What the Big Trials Measured

Two trials used DXA scans to split weight loss into fat and lean tissue:

Sources: the STEP 1 DXA abstract and the SURMOUNT-1 DXA substudy.

Turning those percentages into “how much of the weight I lost was lean” gives different answers. A 2025 joint advisory on nutrition and exercise with these medicines, published in Obesity, reports that in STEP 1, of an average 13.6 kg weight reduction, about 8.3 kg (62%) was fat and about 5.3 kg (38%) was lean mass. In the SURMOUNT-1 substudy, roughly 26% of the weight lost on tirzepatide was lean. A 2025 meta-analysis of nine placebo-controlled trials put it at about 30%.

Do not average these. The trials used different drugs, populations and methods. The honest range from the research is somewhere around a quarter to well over a third of the weight lost being lean tissue, and the advisory notes that roughly half of lean tissue is skeletal muscle.

Dieting Itself Costs Lean Mass

This is the part that gets lost in headlines. In the SURMOUNT-1 substudy, people on placebo, who were simply on a lifestyle programme, also lost lean mass: about a quarter of their weight loss. Losing weight by any route tends to cost some lean tissue unless you take deliberate steps to protect it. These medicines are not uniquely “muscle-wasting”. They make large weight loss possible, which makes the protection plan more important.

The studies also have limits. Only a small subset of each trial had DXA scans. Most participants were women, many were White, and the DXA analyses were not the main trial question. We do not have large, Indian body composition datasets for these medicines yet.

Why Indians Should Pay Particular Attention

South Asians tend to start with less muscle for the same BMI and more fat around the abdomen, the thin-fat pattern we cover in our post on thin-fat syndrome in India. If your starting muscle reserve is already modest, losing a similar percentage leaves you with less to spare. Indian expert groups that have published guidance on GLP-1 therapy this year, as reported in the Indian press, have emphasised the same points: assess nutrition and muscle at baseline, prioritise good-quality protein, combine nutrition with resistance exercise, and use simple strength tests such as handgrip and chair-stand in people at higher risk. The reports we reviewed did not specify a protein number, so we have not quoted one as “the Indian guideline”.

Protecting Muscle: What Guidelines Propose

The advisory above lays out the commonly proposed approach. These are what the document proposes for general adults, not a prescription for you, and your doctor or dietitian should personalise them, especially if you have kidney disease or other conditions.

• Protein. The standard recommended intake is 0.8 g per kg of body weight per day. During active weight reduction, higher targets of about 1.2 to 1.6 g per kg per day have been proposed. The advisory cautions against sustained intakes of 2 g/kg or more and notes that people with kidney disease need individual advice. Our guide to protein requirements for Indians covers vegetarian sources.
• Resistance training. Strength training at least three times a week, alongside about 150 minutes of moderate aerobic activity per week. If you are new to lifting, begin gradually and ask your doctor first.
• Eating enough to eat well. Reduced appetite on these medicines can make it hard to hit protein and micronutrient needs. This is a conversation for your dietitian.
• Sleep and recovery. Muscle repair depends on both. See daily habits to prevent muscle loss.

Measuring What the Scale Cannot

The weighing scale reports one number. A body composition scan splits it into fat mass, lean mass and body water, and repeating it under the same conditions shows direction: is the weight coming off mostly as fat, or is lean mass falling faster than expected?

Be realistic about the tool. Bioimpedance (BIA), the method used by InBody analysers, estimates composition from how an electrical current travels through your body. It is practical and repeatable, but studies comparing it with DXA show systematic differences, and rapid weight loss and fluid shifts, including dehydration from stomach upset, can affect readings. DXA is the reference method for fat and lean mass, though it too measures lean mass, not muscle alone. Our comparison of InBody, DEXA and calipers sets out the trade-offs. The sensible approach is the same device, the same conditions, and trend over single readings, alongside strength tests like handgrip.

If you work in a clinic, our clinic-side monitoring guide covers a practical pathway.

Red Flags and Who Needs Extra Care

Tell your doctor promptly about severe or persistent stomach pain, repeated vomiting, signs of dehydration, or unusual weakness. Older adults, people with kidney disease, those with very low food intake and anyone with existing low muscle mass or sarcopenia warrant extra attention to protein, strength and monitoring. Prescription-only medicines in India should be started and supervised by a qualified doctor, and not bought from unverified online sellers.

For the broader picture of these drugs, see our earlier overview of GLP-1 weight-loss drugs.

Questions to Ask Your Prescriber

1. Which approved indication fits my situation, and what is the plan if my weight loss is faster than expected?
2. How will we check my muscle and strength, not just my weight?
3. What daily protein range suits me, given my kidneys and diet?
4. Can you refer me to a dietitian and, if needed, a physiotherapist for strength work?
5. What is the plan for maintaining my results over time?

Frequently Asked Questions

Do GLP-1 medicines cause muscle loss?

Weight loss on these medicines includes some lean mass, as weight loss by any method does. Trials estimate roughly a quarter to over a third of the weight lost is lean tissue, and about half of lean tissue is muscle. How much depends on protein, activity and how lean mass is measured.

How much protein should I eat on a GLP-1 medicine?

A 2025 advisory notes the standard 0.8 g/kg intake and says higher targets of 1.2 to 1.6 g/kg have been proposed during active weight loss. Individual needs differ, especially with kidney disease. Ask your doctor or a dietitian to set a target for you.

Is strength training necessary?

Guidelines propose resistance training at least three times a week plus regular aerobic activity. It is the best-supported way to help preserve muscle while losing weight. Start gradually and check with your doctor if you have joint problems or a heart condition.

Can a body composition scan show muscle loss?

It can show trends in lean mass, fat mass and water when taken on the same device under the same conditions. It cannot count muscle exactly, and rapid weight loss or dehydration can affect readings, so pair it with strength tests and your doctor’s review.

Will I regain the weight if I stop?

That depends on the individual, the medicine and the lifestyle changes made alongside it. This is a question for your doctor, who can discuss maintenance plans. Do not stop or change a prescribed medicine on your own.

Is it safe for me to use these medicines?

Only a doctor who knows your history can answer that. These are prescription medicines with specific indications. Avoid self-medication and unverified sellers, and discuss your medical history, other medicines and goals with a qualified doctor before any decision.

See Your Starting Point, Not Just Your Weight

If you or someone in your family is on a weight-loss medicine, ask your doctor about tracking muscle and strength alongside weight. Find an InBody test centre near you for a body composition baseline, and read how InBody and DEXA compare if you are deciding between methods.

This article is for general education and is not medical advice. It does not recommend any medicine, dose or product. Prescription medicines should be started, adjusted and stopped only on the advice of a qualified doctor.

Related reading: sarcopenia and muscle loss in India and tracking body composition after bariatric surgery.